Written by the Nuvirox Research Team
KEY POINTS
- IV and injected NAD+ reach the bloodstream directly; oral precursors are converted into NAD+ inside the body.
- A central controversy: infused whole NAD+ may be too large to enter cells efficiently, raising doubts about its advantage over oral precursors.
- Oral NR is the most-studied route for actually raising intracellular NAD+ — and by far the cheapest.
Short answer: the IV wins on bloodstream numbers, but that may be the wrong scoreboard. Intravenous NAD+ bypasses digestion and floods plasma, which sounds decisively better. But a serious scientific objection — voiced by a prominent aging researcher — is that the intact NAD+ molecule is too big to enter cells well and gets broken down anyway, meaning the route that wins on a plasma reading may not win where it counts: inside the cell.
How do the three routes differ?
Oral precursors (nicotinamide riboside, NMN) are capsules your body absorbs and converts stepwise into NAD+. Absorption varies between people, and not all of an oral dose reaches circulation — but the precursor is designed to be taken up by cells and built into NAD+ through natural pathways.
IV therapy infuses NAD+ directly into a vein over a clinic visit, achieving high plasma levels immediately. Injections are a shorter, often subcutaneous or intramuscular version of the same idea. Both bypass the gut.
Why isn't "100% bioavailable" the end of the argument?
Because bioavailability in the blood isn't the same as availability inside your cells, where NAD+ does its work. The widely cited objection comes from Dr. Eric Verdin, president of the Buck Institute for Research on Aging, who has argued that intravenous NAD+ is largely broken down into nicotinamide and that the intact molecule is too big to enter cells efficiently — his view being that oral precursors like NR or NMN are a better bet for most people.
Crucially, no large controlled trials have shown that NAD+ injections or infusions raise intracellular NAD+ more than oral precursors do. The plasma spike is real; the cellular advantage is unproven. That's a meaningful gap when one option costs a fraction of the other.
What does the oral evidence actually show?
This is where oral NR has the documentation. In a randomized crossover trial, 30 middle-aged and older adults taking NR saw NAD+ metabolism rise and tolerated it well. In dose-ranging work, blood NAD+ climbed up to 142% on 1000 mg daily. Oral NR's case for raising NAD+ in people is, frankly, better evidenced than the case for IV doing something oral can't.
STUDY SNAPSHOT
| Route compared | Oral NR (capsule) |
| Evidence | Multiple RCTs show dose-dependent NAD+ rise |
| IV/injection | High plasma levels; intracellular benefit unproven vs oral |
| Cost | Oral: pennies to dollars/day. IV: premium clinic pricing. |
What an IV legitimately offers
To be fair to the drip: some people report a pronounced acute effect from infusions that they don't get from capsules, infusions deliver a known quantity without relying on gut absorption, and clinical supervision can suit people who want oversight. Rapid infusions can also cause flushing, nausea, or a racing-heart sensation, which is why clinics run them slowly. None of that makes the IV more effective at the cellular level — it's a different experience at a much higher price.
Who might reasonably choose what?
If your goal is daily, sustainable, evidence-backed NAD+ support on a normal budget, an oral precursor is the rational default. If you specifically want a clinically supervised, high-intensity experience and the cost is immaterial to you, an IV is an option — just go in clear-eyed that you're paying a large premium for a route whose cellular advantage hasn't been demonstrated. For the everyday format questions, our piece on NAD+ tablets and delivery formats goes deeper.
What you're actually paying for with IV
The price gap between an oral precursor and an NAD+ IV drip is large — often the difference between cents and hundreds of dollars per session — so it's fair to ask what that premium buys. The honest answer is that it mostly buys delivery route and setting, not a proven outcome advantage. IV NAD+ bypasses digestion and can produce a rapid rise, but rapid infusion is also associated with uncomfortable sensations (chest pressure, flushing, nausea) that force slow drip rates. Crucially, there is no robust trial evidence showing IV NAD+ outperforms oral precursors for energy, longevity, or cognition in healthy people.
Injections (subcutaneous or intramuscular NAD+) occupy a middle ground in cost and convenience but share the same core limitation: the clinical outcome evidence is thin regardless of route. Much of what's marketed around IV and injectable NAD+ rests on anecdote and clinic testimonials rather than controlled data.
A practical way to think about route
If your goal is a sustained, modest increase in NAD+ availability with the strongest tolerability record and the lowest cost, oral precursors are the most defensible starting point — they're what the published human trials actually used. IV and injectable approaches may appeal for speed or for medically supervised contexts, but paying a large premium for them should come with clear-eyed awareness that you're not buying proven superiority. Anyone considering IV or injectable NAD+ for a medical reason should discuss it with a clinician rather than a clinic's sales desk.
Frequently asked questions
Is IV NAD+ better than a pill?
It produces higher blood levels, but no controlled trial has shown it raises NAD+ inside your cells more than oral precursors. On the metric that matters, the advantage is unproven.
Why do people feel more from an IV?
The acute plasma spike and the clinical setting may both contribute. A noticeable acute sensation isn't evidence of greater long-term cellular benefit, though.
Are NAD+ injections safe?
When administered by professionals they're generally tolerated, though rapid delivery can cause flushing or nausea. They share the same open question about cellular uptake as IVs.
Is oral NAD+ a waste then?
No — oral NR is actually the most-documented route for raising NAD+ in humans, and it's far cheaper. The capsule is the better-evidenced everyday choice for most people.
From Nuvirox
Why we formulated NAD+ Restore
NAD+ Restore is built around 500 mg of Nicotinamide Riboside Chloride (NR) per two-capsule serving — one of the two most-researched NAD+ precursors, within the dose range used in published human trials. We pair it with 150 mg trans-resveratrol (from Japanese Knotweed) and 50 mg quercetin (from Sophora japonica), polyphenols studied alongside NAD+ pathways for cellular health support, plus 10 mg galactomannans from fenugreek to support absorption.
It ships with a 60-day money-back guarantee — long enough to actually evaluate it the way the research says you should.
Learn more about NAD+ Restore →The bottom line
The IV wins the plasma contest and loses on cost and on proof. Oral NR is the route with the strongest human evidence for actually raising NAD+, at a tiny fraction of the price. Unless you specifically want a supervised, high-intensity experience and don't mind paying for it, the everyday capsule is the more defensible choice.
References
- Martens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9:1286. PMID: 29599478. DOI: 10.1038/s41467-018-03421-7.
- Conze D, Brenner C, Kruger CL. Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. Sci Rep. 2019;9:9772. PMC: PMC6611812. DOI: 10.1038/s41598-019-46120-z.
- Dolopikou CF, et al. Acute nicotinamide riboside supplementation improves redox homeostasis and exercise performance in old individuals: a double-blind cross-over study. Eur J Nutr. 2020;59(2):505–515. PMID: 30725213. DOI: 10.1007/s00394-019-01919-4.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.